Agilisium Achieves Prestigious Amaz on Web Services (AWS) Life Sciences Competency Status.
~This recognition makes the company one of the 28 consulting partners with AWS Life Sciences Competency Status out of the 8300+ AWS Partners globally~
Chennai, 30th July, 2024: Agilisium, a p ioneering leader in Data Analytics, Clo ud, and Life Science solutions, today a nnounced that it has won the coveted AWS Life Sciences Competency status; placing the brand among an exclusive group of 28 Consulting Partners out of 8,300+ AWS Partners globally. This rem arkable achievement demonstrates th e company’s proven expertise in deliv ering transformative cloud solutions t o pharmaceutical companies, seeking to expedite drug discovery, strengthen clinical trials, and develop novel genet ic-based treatments.
Agilisium has developed over 20 GenA I-powered data analytics solutions exe mplifying the company’s innovative ap proach, enabling pharma organisation ons to unlock deeper insights, and acce lerate research and development cycle s; thereby bringing life-saving treatme nts to patients more efficiently. Furthe rmore, Agilisium’s solutions and accel erators can be accessed through the A WS marketplace.
Commenting on the achievement, Mr Raj Babu, Founder and CEO of Agilisiu m said, “Earning the AWS Life Sciences Competency status is a significant mile st mone for Agilisium. This achieveme nt reflects our team’s unwavering ded ication to understanding the complex challenges in the pharma industry and developing solutions that effectively a ddress them. By harnessing the power of our GenAI solutions, we are confide nt that we can usher in a new era of da ta-driven discovery and innovation in life sciences. Additionally, this recogn ition would enable our clients to tran sform data into meaningful insights, u ltimately delivering life-changing the rapies to patients faster, globally”.
As one of the few AWS-certified Data A nalytics partners with specialized exp ertise in the pharmaceutical industry, Agilisium is uniquely positioned to of fer a wide range of AWS services tailor ed for the Life Sciences industry. This includes generative AI solutions, adva nced analytics, data lakes, and machi ne learning, among several others. The company also offers AWS’ MAP (Migra tion Acceleration Program) funding pr ogram and No-Cost Assessment progra m for its clients which significantly he lps clients to accelerate faster Cloud T ransformation journeys.
About Agilisium –
Agilisium is one of the premier Life Sci ences partners for digital innovations. The company delivers cutting-edge sol utions that drive impactful change by combining our strong domain experti rtise with Data, Cloud, GenAI, and Adv anced Analytics. Agilisium collaborate s with leading pharma and biotech co mpanies to provide data-driven insigh ts and innovative solutions across the value chain, helping accelerate drug d iscovery, optimize patient care, achiev e commercial success, streamline pro duct delivery, and foster collaboration . The company’s commitment to rigoro us execution and continuous innovatio tion enables it to shape the future of th e Life Sciences industry.
Website: www.agilisium.com